Viveve Medical, Inc. (VIVE)

Viveve Medical Income Statement

Financials in millions USD. Fiscal year is January - December.

Year Ending	TTM	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017
Revenue	6.83	6.43	5.48	6.57	18.52	15.29
Revenue Growth (YoY)	2.38%	17.28%	-16.57%	-64.54%	21.12%	114.09%
Cost of Revenue	5.71	5.81	5.18	5.55	11.2	7.84
Gross Profit	1.12	0.62	0.3	1.02	7.32	7.44
Selling, General & Admin	13.54	12.51	13.67	22.36	38.57	28.83
Research & Development	8.72	9.67	5.13	8.59	13.72	12.34
Other Operating Expenses	-0.09	-0.2	-0.29	-0.16	0.01	0
Operating Expenses	22.26	22.17	18.79	30.95	52.29	41.17
Operating Income	-21.14	-21.55	-18.5	-29.94	-44.97	-33.73
Interest Expense	1.11	1	0.91	4.35	4.37	3.17
Other Expense / Income	0.09	-0.78	2.13	7.61	-0.01	0.06
Pretax Income	-22.34	-21.77	-21.53	-41.9	-49.32	-36.96
Income Tax	1.57	1.05	-0.29	4.82	-0.14	-0.33
Net Income	-23.92	-22.82	-21.24	-46.72	-49.18	-36.63
Shares Outstanding (Basic)	11	10	2	0	0	0
Shares Outstanding (Diluted)	11	10	2	0	0	0
Shares Change	0.69%	541.22%	1161.00%	301.76%	77.52%	89.72%
EPS (Basic)	-2.29	-2.26	-13.50	-374.40	-1583.50	-2093.62
EPS (Diluted)	-2.29	-2.26	-13.50	-374.40	-1583.50	-2093.62
Free Cash Flow	-16.83	-13.33	-16.02	-32.32	-45.23	-35.76
Free Cash Flow Per Share	-1.58	-1.32	-10.18	-259.03	-1456.33	-2043.78
Gross Margin	16.39%	9.65%	5.40%	15.47%	39.53%	48.69%
Operating Margin	-309.73%	-335.40%	-337.56%	-455.87%	-242.83%	-220.63%
Profit Margin	-350.40%	-355.18%	-387.64%	-711.42%	-265.60%	-239.60%
Free Cash Flow Margin	-246.51%	-207.50%	-292.30%	-492.20%	-244.27%	-233.90%
EBITDA	-20.43	-20.62	-18.78	-28.92	-44.97	-33.67
EBITDA Margin	-299.24%	-320.84%	-342.84%	-440.32%	-242.83%	-220.24%
Depreciation & Amortization	0.81	1.14	1.3	1.18	0.79	0.45
EBIT	-21.23	-21.76	-20.08	-30.1	-45.75	-34.12
EBIT Margin	-311.05%	-338.56%	-366.51%	-458.32%	-247.08%	-223.18%

Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.